Pulmonary sarcoidosis or post-immunotherapy granulomatous reaction induced by the anti-PD-1 monoclonal antibody pembrolizumab: the terminology is not the key point
Ann Oncol
.
2016 Oct;27(10):1974-5.
doi: 10.1093/annonc/mdw256.
Epub 2016 Aug 22.
Authors
S Cousin
1
,
A Italiano
2
Affiliations
1
Early Phase Trials Unit Department of Medicine, Institut Bergonié, Bordeaux, France.
2
Early Phase Trials Unit Department of Medicine, Institut Bergonié, Bordeaux, France a.italiano@bordeaux.unicancer.fr.
PMID:
27551050
DOI:
10.1093/annonc/mdw256
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized / immunology*
Humans
Immunotherapy
Sarcoidosis, Pulmonary*
Substances
Antibodies, Monoclonal, Humanized
pembrolizumab